Therapeutic efficacy of 225Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy
Crossref DOI link: https://doi.org/10.1007/s12149-021-01617-4
Published Online: 2021-05-31
Published Print: 2021-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sen, Ishita
Thakral, Parul
Tiwari, Priya
Pant, Vineet
Das, Subha Shankar
Manda, Divya
Raina, Vinod
Text and Data Mining valid from 2021-05-31
Version of Record valid from 2021-05-31
Article History
Received: 20 January 2021
Accepted: 20 April 2021
First Online: 31 May 2021